GGrantIndex
Sort

51,593 grants matching hepatitis

ATECAR: Asian Training, Education on Cancer & Research

$816,182
Grace X Ma · Temple Univ Of The Commonwealth · U01 · FY2009 · CA

Biomarkers for Steatohepatitis

$816,046
Craig J McClain · University Of Louisville · RC2 · FY2010 · AA

Mechanisms of SARS-CoV-2 pathogenesis during HIV/SIV infection

$815,811
Megan A O'Connor · University Of Washington · R01 · FY2023 · HL

Approaches To Immunological Intervention In Schistosomiasis

$815,605
Thomas Wynn · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Metabolism, infection and immunity in inborn errors of metabolism

$815,546
Peter McGuire · National Human Genome Research Institute · ZIA · FY2015 · HG

Outcomes of non-vitamin K anticoagulants in atrial fibrillation

$815,499
Wayne A Ray · Vanderbilt University Medical Center · R01 · FY2023 · HL

Cardiovascular Risk Reduction in an Aging HIV-Infected Population: The Impact of HCV Co-Infection

$815,255
Virginia Athena Triant · Massachusetts General Hospital · R01 · FY2021 · AG

Project 1: Mechanisms of innate sensing and pathogenesis of SARS-CoV-2

$815,251
Andrea L Cox · Johns Hopkins University · U54 · FY2020 · CA

Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States

$815,131
Xuehong Zhang · Brigham And Women'S Hospital · U01 · FY2022 · CA

Immune analysis of the HBsAg seroclearance response terminating chronic HBV

$814,790
Jody L Baron · University Of California, San Francisco · R01 · FY2025 · AI

Changes in Bone Quality, Sarcopenia and Fat Distribution in HIV/HCV Patients after HCV Therapy

$814,787
Vincent Lo Re · University Of Pennsylvania · R01 · FY2018 · AI

Spatial Models of Intrahepatic Hepatitis C Virus Propagation in Humans

$814,699
Ruy M Ribeiro · Los Alamos Nat Secty-Los Alamos Nat Lab · R01 · FY2018 · AI

Mid Southern Primary Care Networks Node

$814,688
Li-Tzy T Wu · Duke University · UG1 · FY2016 · DA

Xenobiotic Receptors in Mediating the Environmental Effects on Human Disease and Morbidity

$814,679
Wen Xie · University Of Pittsburgh At Pittsburgh · R35 · FY2025 · ES

Ribosome Heterogeneity as a Mechanism for Metabolic Regulation

$814,408
Jean E Schaffer · Joslin Diabetes Center · DP1 · FY2021 · DK

California Hub for HIV/STI/SUD Prevention Research with Reentry Populations

$814,282
Nina Thawata Harawa · University Of California Los Angeles · R61 · FY2024 · DA

Basic and clinical studies in immune function and metabolism

$814,165
Peter McGuire · National Human Genome Research Institute · ZIA · FY2013 · HG

Immunologic and Metabolic Profiles of T cells that control diverse HCV infections

$814,143
Andrea L Cox · Johns Hopkins University · U19 · FY2022 · AI

Expansion of SARS-CoV-2 Testing Supplement, Chicago Clinical Trials Unit

$814,136
Babafemi O Taiwo · Northwestern University At Chicago · UM1 · FY2020 · AI

Genomic Classification of Human Liver Cancer

$813,986
Snorri Thorgeirsson · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Core J: Virology and Molecular Biomarkers Core

$813,884
Guido Silvestri · Emory University · P30 · FY2019 · AI

Exome Sequencing to Identify CVD Risk Variants in Hispanics & African Americans

$813,729
Donald W. Bowden · Wake Forest University Health Sciences · R01 · FY2016 · HG

Restoring awareness of hypoglycemia in type 1 diabetes

$813,114
Michael R Rickels · University Of Pennsylvania · U01 · FY2024 · DK

Novel Catalytic MetalloDrug Targeting IRES RNA for Treatment of HCV Infection

$813,038
Ada S Cowan · Metallopharm, Llc · R44 · FY2012 · AA

Drosophila models of human mitochondrial diseases

$813,032
Norbert Perrimon · Harvard Medical School · R24 · FY2025 · OD